Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
PLoS One. 2020 Oct 16;15(10):e0240715. doi: 10.1371/journal.pone.0240715. eCollection 2020.
This study aimed to determine the probability and prognostic factors of colon cancer-specific mortality (CCSM) and noncancer-specific mortality (NCSM) for patients with stage I/II colon cancer and evaluate the association of age on cause-specific mortality.
From Surveillance, Epidemiology, and End Results (SEER) database, we identified 33152 patients with stage I/II colon cancer undergoing surgery between 2004 and 2011. The cumulative incidence of CCSM and NCSM was calculated, and competing risk analysis was performed to investigate prognostic factors for cause-specific mortality.
In patients <50, 50-75, and >75 years of age, 5-year cumulative incidence of CCSM was 5.7%, 7.8%, and 16.1%, respectively (overall, 10.6%); 5-year cumulative incidence of NCSM was 2.2%, 7.1%, and 26.9%, respectively (overall, 13.8%). The probability of CCSM and NCSM increased with advanced age. The 5-year cumulative incidence of CCSM was higher than NCSM in patients <50 years of age, whereas lower in patients >75 years of age. The probability of CCSM and NCSM was similar in patients 50-75 years of age. Competing-risk multivariable analysis demonstrated that increasing age was a strong predictor of CCSM (per year increase, SHR 1.03,95% confidence interval [CI]: 1.03-1.04). Age was most predictive of NCSM: (per year increase, SHR 1.08, 95% CI: 1.08-1.08).
Age was significantly associated with an increased cumulative incidence of CCSM and NCSM of patients with stage I/II colon cancer underwent surgery. NCSM was a significant competing event and should be adequately considered when performing survival analysis.
本研究旨在确定行手术治疗的 I/II 期结肠癌患者发生结肠癌特异性死亡率(CCSM)和非结肠癌特异性死亡率(NCSM)的概率及其预后因素,并评估年龄对特定原因死亡率的影响。
我们从监测、流行病学和最终结果(SEER)数据库中确定了 33152 例于 2004 年至 2011 年期间行手术治疗的 I/II 期结肠癌患者。计算了 CCSM 和 NCSM 的累积发生率,并采用竞争风险分析来探讨与特定原因死亡率相关的预后因素。
年龄<50、50-75 和>75 岁的患者,5 年 CCSM 的累积发生率分别为 5.7%、7.8%和 16.1%(总体为 10.6%);5 年 NCSM 的累积发生率分别为 2.2%、7.1%和 26.9%(总体为 13.8%)。随着年龄的增长,CCSM 和 NCSM 的发生概率逐渐增加。年龄<50 岁的患者中,CCSM 的 5 年累积发生率高于 NCSM,而年龄>75 岁的患者中则相反。50-75 岁的患者中,CCSM 和 NCSM 的发生概率相似。竞争风险多变量分析表明,年龄的增加是 CCSM 的一个强有力的预测因素(每年增加,SHR 1.03,95%置信区间[CI]:1.03-1.04)。年龄对 NCSM 的预测作用最大:(每年增加,SHR 1.08,95%CI:1.08-1.08)。
年龄与行手术治疗的 I/II 期结肠癌患者 CCSM 和 NCSM 的累积发生率显著相关。NCSM 是一个重要的竞争事件,在进行生存分析时应充分考虑。